157 related articles for article (PubMed ID: 37634703)
1. No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study.
Davidson M; Evrenoglou T; Graña C; Chaimani A; Boutron I
J Clin Epidemiol; 2023 Oct; 162():90-97. PubMed ID: 37634703
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials.
Davidson M; Evrenoglou T; Graña C; Chaimani A; Boutron I
BMC Med Res Methodol; 2024 Jan; 24(1):9. PubMed ID: 38212714
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles: A Systematic Review.
Bai AD; Jiang Y; Nguyen DL; Lo CKL; Stefanova I; Guo K; Wang F; Zhang C; Sayeau K; Garg A; Loeb M
JAMA Netw Open; 2023 Jan; 6(1):e2253301. PubMed ID: 36705921
[TBL] [Abstract][Full Text] [Related]
4. Transparency and reporting characteristics of COVID-19 randomized controlled trials.
Kapp P; Esmail L; Ghosn L; Ravaud P; Boutron I
BMC Med; 2022 Sep; 20(1):363. PubMed ID: 36154932
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles.
Janda G; Khetpal V; Shi X; Ross JS; Wallach JD
JAMA Netw Open; 2022 Dec; 5(12):e2245847. PubMed ID: 36484989
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Janiaud P; Axfors C; Schmitt AM; Gloy V; Ebrahimi F; Hepprich M; Smith ER; Haber NA; Khanna N; Moher D; Goodman SN; Ioannidis JPA; Hemkens LG
JAMA; 2021 Mar; 325(12):1185-1195. PubMed ID: 33635310
[TBL] [Abstract][Full Text] [Related]
8. Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study.
Oikonomidi T; Boutron I; Pierre O; Cabanac G; Ravaud P;
BMC Med; 2020 Dec; 18(1):402. PubMed ID: 33334338
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
[TBL] [Abstract][Full Text] [Related]
10. Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis.
Otridge J; Ogden CL; Bernstein KT; Knuth M; Fishman J; Brooks JT
JMIR Public Health Surveill; 2022 Jul; 8(7):e35276. PubMed ID: 35544426
[TBL] [Abstract][Full Text] [Related]
11. Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review.
Zeraatkar D; Pitre T; Leung G; Cusano E; Agarwal A; Khalid F; Escamilla Z; Cooper MA; Ghadimi M; Wang Y; Verdugo-Paiva F; Rada G; Kum E; Qasim A; Bartoszko JJ; Siemieniuk RAC; Patel C; Guyatt G; Brignardello-Petersen R
BMJ Med; 2022; 1(1):e000309. PubMed ID: 36936583
[TBL] [Abstract][Full Text] [Related]
12. Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.
Gehanno JF; Grosjean J; Darmoni SJ; Rollin L
PLoS One; 2022; 17(8):e0264661. PubMed ID: 35947594
[TBL] [Abstract][Full Text] [Related]
13. Characterization and Reach of Orthopaedic Research Posted to Preprint Servers: Are We "Undercooking" Our Science?
Rizk AA; Arza RA; Jella TK; Cwalina TB; Sanghvi PA; Hadad MJ; Pumo TJ; Kamath AF
Clin Orthop Relat Res; 2023 Aug; 481(8):1491-1500. PubMed ID: 36897188
[TBL] [Abstract][Full Text] [Related]
14. Pre2Pub-Tracking the Path From Preprint to Journal Article: Algorithm Development and Validation.
Langnickel L; Podorskaja D; Fluck J
J Med Internet Res; 2022 Apr; 24(4):e34072. PubMed ID: 35285808
[TBL] [Abstract][Full Text] [Related]
15. Robustness of evidence reported in preprints during peer review.
Nelson L; Ye H; Schwenn A; Lee S; Arabi S; Hutchins BI
Lancet Glob Health; 2022 Nov; 10(11):e1684-e1687. PubMed ID: 36240832
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
Gianola S; Jesus TS; Bargeri S; Castellini G
PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
[TBL] [Abstract][Full Text] [Related]
17. Completeness and consistency of primary outcome reporting in COVID-19 publications in the early pandemic phase: a descriptive study.
Stoll M; Lindner S; Marquardt B; Salholz-Hillel M; DeVito NJ; Klemperer D; Lieb K
BMC Med Res Methodol; 2023 Jul; 23(1):173. PubMed ID: 37516878
[TBL] [Abstract][Full Text] [Related]
18. Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.
Morand A; Urbina D; Giovannini-Chami L; Fabre A
Arch Pediatr; 2021 Aug; 28(6):464-469. PubMed ID: 34140220
[TBL] [Abstract][Full Text] [Related]
19. Day-to-day discovery of preprint-publication links.
Cabanac G; Oikonomidi T; Boutron I
Scientometrics; 2021; 126(6):5285-5304. PubMed ID: 33897069
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation.
Bero L; Lawrence R; Leslie L; Chiu K; McDonald S; Page MJ; Grundy Q; Parker L; Boughton S; Kirkham JJ; Featherstone R
BMJ Open; 2021 Jul; 11(7):e051821. PubMed ID: 34272226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
